Trial intelligence / Profile preview

Prograf-XL vs Prograf in Liver Transplant Recipients

NCT00720408Phase 3Completed

Sponsor
Astellas Pharma
Start
Dec 2007
Primary completion
Sep 2009
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tacrolimus in liver transplantation, sponsored by Astellas Pharma. Started Dec 2007; status: completed.

02

Drugs

tacrolimus
03

Conditions

liver transplantation

Beyond the preview

Go deeper on NCT00720408.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00720408.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call